Glomerulonephritis Treatment in Bathinda: Symptoms, Diagnosis & Care

Every day, across the hospitals and clinics of Bathinda and the broader Malwa region of Punjab, patients arrive with the same cluster of bewildering symptoms: foam in the urine, swelling around the eyes and ankles, blood-tinged urine, and blood pressure that cannot be controlled. The cause, in a significant proportion of these cases, is a condition most patients have never heard of — glomerulonephritis.

Glomerulonephritis (GN) is not a single disease. It is a family of inflammatory conditions affecting the glomeruli — the microscopic filtration units within the kidney — that collectively represent one of the leading causes of chronic kidney disease and kidney failure worldwide. Left undiagnosed or inadequately treated, GN can progress to end-stage kidney failure within months or years. Diagnosed and managed early, many forms can be controlled, stabilised, or sent into complete remission.

This guide is written specifically for patients in Bathinda and surrounding areas of Punjab who have been told they may have a kidney condition, who are experiencing unexplained urinary or kidney symptoms, or who are seeking specialist nephrology care closer to home. It covers what glomerulonephritis is, how it presents, how it is diagnosed, and what modern treatment looks like — explained in clear, accessible terms.

Key Fact: Glomerulonephritis accounts for approximately 20–25% of all cases of end-stage kidney failure requiring dialysis or transplant in India. It is treatable — but only if it is caught and correctly managed.

What Is Glomerulonephritis?

To understand glomerulonephritis, it helps to understand what glomeruli are and what they do. Each kidney contains approximately one million nephrons — the functional filtration units. At the centre of each nephron sits the glomerulus: a tiny knot of capillaries encased in a membrane, through which blood is filtered at high pressure. Water, waste products, and small molecules pass through; large proteins and blood cells are meant to stay behind.

In glomerulonephritis, this filtration membrane becomes inflamed and damaged. The causes of this inflammation vary enormously — autoimmune attack, immune complex deposition, infection, systemic disease, or genetic predisposition — but the consequences follow a common pattern: the damaged membrane begins to leak protein and red blood cells into the urine, loses its ability to clear waste products from the blood, and over time undergoes scarring (glomerulosclerosis) that permanently reduces kidney function.

GN can be classified in two broad ways:

• By clinical syndrome: nephritic syndrome (haematuria, hypertension, mild proteinuria, oedema) vs. nephrotic syndrome (heavy proteinuria, oedema, low albumin, high cholesterol) — or a mixed picture of both.
• By histological pattern: determined by kidney biopsy — the definitive investigation that identifies the specific type of GN and guides treatment decisions.

GN may be acute (sudden onset, often reversible), chronic (slow and progressive), or rapidly progressive — the most urgent form, in which kidney function can decline to dialysis-requiring levels within days to weeks if not treated immediately.

Symptoms of Glomerulonephritis

The symptoms of GN depend on the specific type and clinical syndrome. Some patients present dramatically; others are discovered incidentally on routine urine testing. The following are the most important symptoms to recognise:

1. Blood in the Urine (Haematuria)

Haematuria — blood in the urine — is one of the hallmark symptoms of glomerulonephritis, and it appears in two forms. Macroscopic (visible) haematuria causes the urine to appear pink, red, or cola-coloured — alarming and impossible to miss. Microscopic haematuria is detectable only on urine testing, invisible to the naked eye, but equally significant clinically. In GN, haematuria originates from damaged glomerular capillaries and the presence of red cell casts on urine microscopy confirms a glomerular source.

Cola-coloured or tea-coloured urine appearing 1–3 weeks after a throat or skin infection is a classic sign of post-infectious glomerulonephritis — a pattern seen especially in children and young adults. It requires urgent evaluation.

2. Frothy or Foamy Urine (Proteinuria)

Persistent foam or froth in the urine — particularly when it does not clear after several minutes — indicates significant protein leakage through the damaged glomerular membrane. In nephrotic syndrome, protein losses can exceed 3.5 grams per day, causing the albumin level in the blood to fall dramatically. Low serum albumin leads directly to the next symptom.

3. Swelling (Oedema)

Swelling is one of the most visible and distressing symptoms of glomerulonephritis. It results from two mechanisms working together: fluid retention due to impaired kidney sodium excretion, and reduced oncotic pressure (the force that keeps fluid in blood vessels) due to protein loss. The swelling typically begins around the eyes — periorbital oedema, characteristically worse in the morning — then progresses to the ankles, feet, and legs. In severe cases, fluid accumulates in the abdomen (ascites) and around the lungs (pleural effusions).

4. High Blood Pressure (Hypertension)

Hypertension in GN results from sodium and water retention, activation of the renin-angiotensin-aldosterone system (RAAS) by ischaemic kidney tissue, and impaired renal pressure regulation. It is both a symptom and a driver of further kidney damage — uncontrolled hypertension accelerates glomerulosclerosis and worsens proteinuria. In some patients, GN-related hypertension is the presenting finding that leads to the diagnosis.

5. Decreased or Altered Urine Output

In rapidly progressive GN (RPGN), urine output can fall dramatically — sometimes to near-zero (oliguria or anuria) — as the glomeruli are acutely destroyed faster than the kidneys can compensate. In slower-progressing forms, patients may notice a gradual reduction in urine output, or a change in its character (darker colour, persistent foam).

6. Systemic Symptoms Suggesting Underlying Disease

When GN is secondary to a systemic condition, additional symptoms may provide important diagnostic clues:

• Joint pain, facial rash, photosensitivity, oral ulcers — suggesting lupus (SLE)
• Nosebleeds, sinusitis, upper respiratory symptoms — suggesting ANCA vasculitis (GPA)
• Coughing up blood (haemoptysis) alongside haematuria — suggesting anti-GBM disease or vasculitis
• Skin rash, abdominal pain, joint swelling in children — suggesting IgA vasculitis (HSP)

 

Red Flag: Any combination of blood in the urine, persistent frothy urine, facial or ankle swelling, and high blood pressure requires urgent kidney function testing and nephrology referral. Do not wait.

Read More :- Best Nephrologists in Punjab. Explain: Does drinking a lot of water keep kidneys healthy?

 

Types of Glomerulonephritis: A Clinical Overview

GN encompasses multiple distinct conditions. The table below summarises the most important types — what causes them, how they present, and how they are treated. Definitive diagnosis requires kidney biopsy in most cases.

Type of GN	What It Is	Typical Presentation	Treatment Approach
IgA Nephropathy (Berger’s Disease)	Most common primary GN worldwide; IgA deposits in glomeruli	Haematuria after infections; mild proteinuria; variable course	ACE inhibitors, steroids, fish oil; tonsillectomy in selected cases
Minimal Change Disease	Podocyte injury with no visible changes on light microscopy	Sudden heavy proteinuria; oedema; normal BP; common in children	High-dose steroids; usually respond well; may relapse
Focal Segmental Glomerulosclerosis	Scarring of parts of some glomeruli; primary or secondary (obesity/HIV)	Nephrotic-range proteinuria; hypertension; progressive CKD	Steroids, calcineurin inhibitors; treat underlying cause
Membranous Nephropathy	IgG deposits along glomerular basement membrane; often autoimmune	Heavy proteinuria; oedema; high clot risk; middle-aged adults	Monitoring vs rituximab/cyclophosphamide; anticoagulation
Lupus Nephritis	Kidney involvement in systemic lupus erythematosus (SLE)	Haematuria, proteinuria, hypertension, declining GFR in SLE patients	Hydroxychloroquine, steroids, mycophenolate, belimumab
Post-infectious GN	Immune complex deposits after bacterial (strep) or viral infections	Haematuria, oedema, hypertension 1–3 weeks after throat/skin infection	Usually self-limiting; BP control; antibiotics if infection persists
Anti-GBM Disease (Goodpasture’s)	Autoantibodies attack the glomerular basement membrane and lungs	Rapidly progressive GN; haemoptysis; life-threatening without treatment	Emergency plasmapheresis + cyclophosphamide + steroids
ANCA Vasculitis	Systemic vasculitis (GPA, MPA) causing necrotising GN	Rapidly progressive GN; haematuria, pulmonary haemorrhage possible	Rituximab or cyclophosphamide + high-dose steroids; maintenance therapy

How Is Glomerulonephritis Diagnosed?

The diagnosis of GN requires a systematic approach — moving from simple urine and blood tests to specialist investigations and, in most cases, kidney biopsy. Below is the complete diagnostic pathway used in nephrology practice:

Investigation	Level	What It Tells the Nephrologist
Urine Dipstick & Microscopy	First-line	Detects blood, protein, and casts (red cell casts = glomerular bleeding)
Urine ACR / Protein-Creatinine	First-line	Quantifies protein leak; ACR > 300 mg/g = nephrotic-range proteinuria
Serum Creatinine + eGFR	First-line	Measures current kidney filtration capacity; establishes CKD stage
Full Blood Count	First-line	Detects anaemia; elevated WBC may suggest infection or systemic disease
Complement C3 / C4	Second-line	Low C3 in post-infectious GN, lupus nephritis, MPGN; helps narrow diagnosis
ANA + Anti-dsDNA	Second-line	Positive in lupus nephritis; anti-dsDNA correlates with disease activity
ANCA (PR3 + MPO)	Second-line	Positive in ANCA vasculitis (GPA, MPA); guides treatment urgency
Anti-GBM Antibodies	Second-line	Positive in Goodpasture’s disease; requires emergency treatment
Anti-PLA2R Antibody	Second-line	Specific marker for primary membranous nephropathy; guides biopsy decision
Kidney Ultrasound	Imaging	Assesses kidney size, echogenicity, obstruction; bilateral small kidneys suggest chronicity
Kidney Biopsy	Definitive	Gold standard for GN diagnosis; identifies histological pattern, activity, chronicity index

The Kidney Biopsy — The Gold Standard

For the majority of GN types, kidney biopsy is the only way to make a definitive diagnosis, assess disease activity, determine the degree of scarring (chronicity index), and guide treatment decisions. At Dhiman’s Gastro Clinics, kidney biopsy is performed under real-time ultrasound guidance as a day procedure, with a small needle introduced through the back under local anaesthesia. The tissue sample is sent for light microscopy, immunofluorescence, and electron microscopy — together providing a complete histological picture of the kidney.

The biopsy result determines not just the type of GN but also how aggressively it needs to be treated. High disease activity with minimal scarring warrants aggressive immunosuppressive therapy; extensive scarring with low activity may mean supportive care is more appropriate.

Who needs a kidney biopsy? Any patient with unexplained proteinuria above 1g/day, haematuria with proteinuria, rapidly declining kidney function, or suspected systemic disease affecting the kidneys should be evaluated for biopsy by a nephrologist.

 

Glomerulonephritis Treatment: A Comprehensive Approach

Treatment of GN is highly individualised — it depends on the specific histological type, the clinical syndrome, disease activity, degree of existing scarring, and the patient’s overall health profile. There is no universal treatment for all forms of GN. The approach combines disease-specific immunosuppressive therapy with supportive measures that protect the kidneys from further damage.

1. Immunosuppressive Therapy

For immune-mediated forms of GN — which includes most primary GN types and many secondary forms — immunosuppressive treatment is the cornerstone of management. The specific agents used depend on the GN type:

• Corticosteroids (prednisolone/methylprednisolone): First-line for minimal change disease, focal segmental glomerulosclerosis, lupus nephritis, and many other GN types. Used in high doses for induction and tapered for maintenance. Pulse IV methylprednisolone is used for rapidly progressive GN.
• Cyclophosphamide: Combined with steroids for severe lupus nephritis, ANCA vasculitis, and anti-GBM disease. Highly effective but carries risks of infection, bone marrow suppression, and in high cumulative doses, fertility effects.
• Rituximab: An anti-CD20 monoclonal antibody increasingly used as an alternative to cyclophosphamide for ANCA vasculitis and membranous nephropathy. Excellent efficacy with a more favourable side-effect profile.
• Mycophenolate Mofetil (MMF): Widely used for maintenance therapy in lupus nephritis and as induction therapy in membranous nephropathy. Safer than cyclophosphamide for long-term use.
• Calcineurin Inhibitors (tacrolimus, cyclosporine): Used for focal segmental glomerulosclerosis and membranous nephropathy, particularly in patients who do not respond to steroids.
• Hydroxychloroquine: Standard background therapy in all patients with lupus nephritis; reduces flares and improves long-term outcomes.

2. Supportive and Renoprotective Therapy

Alongside disease-specific treatment, all GN patients require supportive measures to slow CKD progression and protect cardiovascular health:

• ACE Inhibitors / ARBs: Reduce intraglomerular pressure and proteinuria, slowing progression in all proteinuric kidney diseases. Usually prescribed regardless of GN type.
• SGLT2 Inhibitors: Empagliflozin and dapagliflozin have demonstrated kidney-protective effects in proteinuric CKD, including some GN types, and are increasingly used as adjunctive therapy.
• Blood Pressure Control: Target BP below 130/80 mmHg. Strict BP control is essential in all GN patients — uncontrolled hypertension dramatically accelerates scarring.
• Anticoagulation: Nephrotic syndrome — particularly membranous nephropathy — carries a significant thrombosis risk due to urinary loss of anticoagulant proteins. Anticoagulation is indicated in high-risk patients.
• Lipid-lowering therapy: Nephrotic syndrome causes elevated cholesterol; statins are routinely used to reduce cardiovascular risk.
• Dietary management: Low-sodium diet (under 2,300 mg/day), moderate protein intake, and fluid management appropriate to the clinical syndrome.

3. Emergency Treatment for Rapidly Progressive GN (RPGN)

RPGN — particularly anti-GBM disease and ANCA vasculitis — is a nephrological emergency. Treatment must begin within hours of diagnosis to have any chance of preserving kidney function. Emergency protocols include:

• IV pulse methylprednisolone (1g daily for 3 days)
• Plasmapheresis (plasma exchange) to remove circulating antibodies — critical in anti-GBM disease
• Cyclophosphamide or rituximab commenced immediately
• Dialysis if kidney function has already collapsed

 

RPGN Warning: If you develop rapidly worsening kidney function — sudden decrease in urine output, rapidly rising creatinine, haematuria, and breathlessness — seek emergency nephrology care immediately. Every hour matters.

4. Treatment of Underlying Disease

In secondary GN, treating the underlying systemic disease is central to GN management. Achieving remission of lupus, controlling ANCA vasculitis, treating underlying infection, or removing a causative drug removes the driving force of glomerular inflammation. Without treating the root cause, GN will persist or relapse regardless of symptomatic management.

5. Management of ESRD from GN

When GN progresses to end-stage kidney failure despite treatment, renal replacement therapy becomes necessary. Options include haemodialysis, peritoneal dialysis, and kidney transplantation. Importantly, some forms of GN — particularly IgA nephropathy, focal segmental glomerulosclerosis, and membranous nephropathy — can recur in a transplanted kidney, requiring ongoing nephrologist monitoring post-transplant.

 

Glomerulonephritis Care Near Bathinda, Punjab

Bathinda sits at the heart of the Malwa region — one of Punjab’s most agriculturally active but also most medically underserved areas in terms of specialist kidney care. Patients in Bathinda, Mansa, Muktsar, Faridkot, and surrounding areas who require specialist nephrology evaluation — including kidney biopsy, immunosuppressive therapy monitoring, and dialysis — have historically had to travel long distances to Chandigarh, Ludhiana, or Delhi for care.

Dr. Deepali Kaushal‘s practice at Dhiman’s Gastro Clinics in Khanna provides patients from Bathinda and the broader Malwa and Doaba regions with accessible, consultant-level nephrology care without the need for distant travel. Khanna is well connected by road and rail to Bathinda and surrounding districts, and offers the full spectrum of nephrology services — including kidney biopsy, initiation and monitoring of immunosuppressive therapy, dialysis services, and transplant evaluation — in a single, specialised centre.

For families managing a new diagnosis of glomerulonephritis, this accessibility is not merely a convenience — it is clinically meaningful. Frequent follow-up, close monitoring of treatment response, and rapid escalation when disease activity increases are all essential to good GN outcomes. These are difficult to achieve when specialist care requires a full-day journey.

📍  Patients from Bathinda, Mansa, Muktsar, Faridkot, and surrounding areas can access Dr. Deepali Kaushal’s nephrology services at Dhiman’s Gastro Clinics, Khanna — approximately 1.5 to 2 hours from Bathinda via NH-7. Call +91 77194 80279 to book.

Read More :- What is Chronic Kidney Disease (CKD)? Stages, Symptoms & Early Warning Signs

Living with Glomerulonephritis: What Patients Should Know

A diagnosis of glomerulonephritis is life-changing, but it is not life-ending. With the right specialist care, many patients achieve complete remission and live full, healthy lives. Here is what matters most for long-term outcomes:

• Keep all follow-up appointments: GN is a dynamic condition. Disease activity fluctuates, relapses can occur, and treatment requires regular adjustment. Missing follow-up is the most common reason for preventable progression.
• Monitor your urine at home: Persistent foam in urine signals worsening proteinuria. Blood-tinged urine after a cold or infection may signal a GN flare. Report changes to your nephrologist promptly.
• Take medications exactly as prescribed: Immunosuppressive drugs must be taken at the correct dose and on schedule. Stopping steroids abruptly or reducing doses without medical advice can trigger dangerous disease rebound.
• Protect yourself from infection: Immunosuppressive therapy reduces immune defences. Avoid crowded places during treatment initiation, maintain vaccinations (after discussing timing with your nephrologist), and seek immediate care for any signs of infection.
• Manage blood pressure diligently: Home BP monitoring and daily BP recording, shared at each clinic visit, is standard practice for GN patients. Target below 130/80 mmHg.
• Adopt a kidney-protective diet: Low sodium, moderate protein, and — if phosphate or potassium are elevated — appropriate dietary restriction guided by your nephrologist or renal dietitian.
• Understand your specific GN type: Each type has a different natural history, relapse pattern, and response to treatment. Ask your nephrologist specifically: What type do I have? What is the expected course? What does remission look like? What triggers a relapse?

Key Takeaways for Patients in Bathinda

• GN is a family of inflammatory kidney diseases — not a single condition. Treatment is type-specific and must be guided by kidney biopsy in most cases.
• Symptoms include blood and foam in urine, swelling, and high BP — often appearing in combination. Any of these warrants urgent nephrology evaluation.
• Some forms of GN are nephrological emergencies — particularly anti-GBM disease and ANCA vasculitis. Delays in treatment can cost function irreversibly.
• Modern treatment achieves remission in many GN types — with the right immunosuppressive therapy, monitored by an experienced nephrologist.
• Patients in Bathinda can access specialist care at Khanna — without the need for travel to Chandigarh or Delhi.
• Early diagnosis and consistent follow-up are the most important factors — in determining long-term kidney outcomes in GN.

 

“Glomerulonephritis does not announce itself loudly. But it does leave signs. Learning to read those signs — and acting on them quickly — is how kidneys are saved.”